Unlocking the Potential of Open Source Models: Strategies to Navigate Barriers in Development and Adoption
Speaker(s)
Moderator: Renée JG Arnold, PharmD, RPh, National Institutes of Health/NHLBI and BioHealth Innovation, Inc., Bethesda, MD, USA
Speakers: Dan Ollendorf, PhD, Institute for Clinical and Economic Review, Boston, MA, USA; Rob M. Boer, PhD, Abbvie, Irvine, CA, USA; Elisabeth Anne Louise Fenwick, PhD, OPEN Health Communications, London, LON, UK
Presentation Documents
In this forum, we will explore innovative approaches to surmounting these barriers associated with OSMs, offering three distinct viewpoints. Dr. Elisabeth Fenwick will represent the academic/consultant perspectives, considering these individuals are often employed, via their affiliated institutions, to provide many of the models designated by the pharmaceutical industry. Dr. Daniel Ollendorf, representing the de facto health technology assessment (HTA) authority in the United States, will elaborate on the HTA perspective regarding OSMs. Dr. Rob Boer will provide insights into the pharmaceutical industry's standpoint on OSMs. The discussion will be enriched with an interactive Q&A session, fostering dynamic engagement and knowledge exchange.
Code
119
Topic
Methodological & Statistical Research